In patients with G1 tumours the 5-year DSS rate was 89 and 85% when nuclear YB-1 expression was low at the IF and the TC, respectively, vs a 71% 5-year DSS for G1 grade tumours when YB-1 expression was high. The gene discussed is YBX1; the disease is neoplasm.